Drug Discovery

ACROBiosystems DDW white paper
#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #GMP

Diving deep into cell therapy: An industry perspective

Cell therapy research has never been more exciting with all of the research ongoing. Learn more about the trends, insights, and perspectives from ACROBiosystems as a manufacturer of cell therapy reagents, including topics like: CAR-NK research Developing new CAR constructs Evaluation CAR expression detection Role of GMP Manufacturing in cell… Read More

#Resources

#Data #Drug development #Gene sequencing #Genome sequencing #Genomics #Healthcare #Precision medicine #Trusted research environment

Why Trusted Research Environments are key to the future of genomics  

Genomics is driving a revolution in drug development and, in the long run, the state of public healthcare. Advances in sequencing are leading to scientific breakthroughs in preventative care, faster diagnoses, and proactive medical interventions. Jack Dix, Head of Healthcare Strategy and Consulting at Kainos, expands.  Genetic… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Breast cancer #Cancer research #CAR-T #Drug discovery #Immunotherapy #Oncology #Pancreatic cancer #Prostate cancer #Solid tumours

This week in drug discovery (20-24 March)

News round-up for 20-24 March by DDW Digital Content Editor Diana Spencer.  This week we have seen a number of developments in the treatment of solid tumours hitting the headlines. Pennsylvania researchers may have found a way to boost CAR-T therapy in these tumours, previously only successful in… Read More

#News

Cancer cell
#Breast cancer #Cancer research #Cancer treatment #Drug development #Drug discovery #Oncology

New global cancer research DDW eBook

This latest ebook sponsored by Sino Biological features insight on how the global drug discovery and development sector is making breakthroughs in cancer research.  Download this exclusive eBook to learn more about:  The global developments tackling the burden of cancer  … Read More

#News

#Collaboration #Drug development #Drug discovery #Partnership

Industry collaborations advancing drug discovery

Strategic research partnerships bring together knowledge, expertise and technologies, allowing advancements in our understanding of diseases and therapeutics that would not be possible in isolation. Optibrium and PostEra integrate AI drug discovery solutions Optibrium and PostEra plan to integrate Optibrium’s StarDrop platform with PostEra’s Manifold software. Read More

#Editor's Choice #News

#Drug development #Drug discovery #eBook #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines

eBook: mRNA development, manufacturing, and beyond

A new eBook is now available entitled ‘Riding the mRNA highway: development, manufacturing, and beyond’, sponsored by Thermo Fisher Scientific. Download the eBook to learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications. Topics covered… Read More

#News

#Drug development #Drug discovery #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines

Riding the mRNA highway: development, manufacturing, and beyond

Download this eBook to learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications. Topics covered in the eBook include: Expert views on mRNA development and manufacturing Advantages of mRNA processes compared to traditional vaccine manufacturing Best practices for… Read More

#Resources

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

Weekly drug discovery highlights podcast: Listen now

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In the news this week, we have covered a number of early-stage studies that could… Read More

#News

#Drug development #Drug discovery #Oncology

New podcast on bringing new drugs to untreatable diseases

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this latest episode, DDW’s Megan Thomas is in conversation with Dr Simon Fricker, who… Read More

#News

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

This week in drug discovery (13-17 March)

News round-up for 13-17 March by DDW Digital Content Editor Diana Spencer.  In the news this week we have covered a number of early-stage studies that could lead to potentially huge breakthroughs in the treatment of metastatic breast cancer, long Covid, bacterial diseases, bone cancer, and autoimmune… Read More

#News

#3D modelling #Biochemistry #CRISPR #DNA #Drug discovery #Gene editing #Genomics #Mass spectrometry / NMR #Screening

Podcast: Mass spectrometry and CRISPR

This is the latest episode of the free DDW podcast, “Mass spectrometry and CRISPR are pillars of drug discovery”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How ASMS offers more than seeing what sticks” and “… Read More

#News

Atrial fibrillation
#Acesion Pharma #Cardiovascular disease #Clinical trial #Drug discovery #Phase II trial

Success for first new approach to atrial fibrillation for 20 years

The primary endpoint has been achieved in a Phase II trial of AP30663, a first-in-class SK ion channel inhibitor for conversion of atrial fibrillation (AF) to normal sinus rhythm. Acesion Pharma enrolled 63 patients with a current episode of AF in the trial and tested two… Read More

#News

#Biotechnology #Drug development #Neurodegenerative disorders #Neuroscience #Seed funding

€28M for neurodegenerative disease treatments

Teitur Trophics, a biotech company developing new treatments for patients suffering from neurodegenerative diseases, has complete a €28M Series A financing.   The financing was co-led by Sunstone Life Science Ventures and Sound Bioventures, with participation from new investors, Industrifonden, Innovestor’s Life Science Fund and P53 Invest. The… Read More

#Business & Investment #News

#Drug development #High throughput screening #Immunology / Virology & Vaccines #IVT #mRNA #RNA #Thermo Fisher Scientific

New listicle: Five tips on scaling up IVT for mRNA production

The success of messenger RNA or mRNA vaccines in the fight against the global SARS-CoV-2 crisis brings a new era of vaccine development. In vitro transcription, or IVT, is a complex reaction, requiring key components like an RNA polymerase, nucleotides, and a DNA template to make each mRNA. By partnering… Read More

#Editor's Choice #News

#Drug development #High throughput screening #Immunology / Virology & Vaccines #IVT #mRNA #RNA #Thermo Fisher Scientific

Listicle: Five tips on scaling up IVT for mRNA production

In this listicle, Thermo Fisher Scientific outlines five measures to help you ensure consistency in your workflow and produce reproducible, high-quality batches of IVT mRNA at scale. The success of messenger RNA (mRNA) vaccines in combatting the global SARS-CoV-2 crisis brings a new era of vaccine development. Read More

#Listicles #Videos

Brain Awareness Week
#Brain #Brain Awareness Week #Brain disease #Dementia #Drug discovery #Parkinson's #Stroke

Brain Awareness Week: the wonders of brain science

DDW’s Diana Spencer reviews some of the advances in drug discovery for diseases of the brain in the last month. Brain Awareness Week is an annual global campaign that takes place from March 13-19, aimed at raising awareness and support for brain science and issues related… Read More

#Exclusive Content